Two Sigma Investments’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-299,633
| Closed | -$710K | – | 3387 |
|
|
2023
Q4 | $710K | Buy |
299,633
+162,163
| +118% | +$384K | ﹤0.01% | 2196 |
|
|
2023
Q3 | $192K | Buy |
137,470
+23,967
| +21% | +$33.6K | ﹤0.01% | 2573 |
|
|
2023
Q2 | $344K | Buy |
+113,503
| New | +$344K | ﹤0.01% | 2402 |
|
|
2022
Q4 | – | Sell |
-10,258
| Closed | -$123K | – | 3091 |
|
|
2022
Q3 | $123K | Buy |
+10,258
| New | +$123K | ﹤0.01% | 2150 |
|
|
2022
Q2 | – | Sell |
-22,966
| Closed | -$259K | – | 3000 |
|
|
2022
Q1 | $259K | Buy |
+22,966
| New | +$259K | ﹤0.01% | 2225 |
|
|
2021
Q4 | – | Sell |
-8,928
| Closed | -$206K | – | 3258 |
|
|
2021
Q3 | $206K | Buy |
+8,928
| New | +$206K | ﹤0.01% | 2308 |
|